Glaucoma Surgery Devices Market Trends, Review, and Forecast by 2026 | Abbott Laboratories, Glaukos Corporation, Alcon, Inc.

Glaucoma Surgery Devices Market

Glaucoma surgery devices are expected to gain momentum in the future since they serve an important role in treating glaucoma. The primary goal of these devices is to attain intraocular pressure stabilisation or decrease (IOP). Because of the necessity for quicker glaucoma treatment to avoid vision loss, the need for effective glaucoma surgical technologies is constantly increasing. High incidence of glaucoma across the world, as well as the rise in the use of glaucoma procedures, are two additional significant factors likely to support growth of the global glaucoma surgery devices market in the near future.

Read Report Overview - https://www.transparencymarketresearch.com/glaucoma-surgery-devices-market.html

In addition, the emergence of novel glaucoma treatment procedures, such as minimally invasive glaucoma surgery (MIGS) devices, has aided in the expansion of the glaucoma surgery devices market. However, in several emerging and undeveloped nations, a lack of understanding regarding glaucoma and the equipment connected with it is impeding market expansion.

In the near future, the rising demand for minimally invasive glaucoma surgery (MIGS) treatments is likely to increase demand for improved glaucoma surgery instruments. MIGS techniques and devices are becoming more popular because of their advantages such as lower costs, faster recovery times, and shorter operation times. These surgeries also come with a lower chance of post-surgical problems such as hypotony.

Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=40916

Glaucoma Surgery Devices Market - Overview

Glaucoma surgery continues to evolve. Many new devices that are currently under investigation or that were recently introduced onto the market use existing physiologic pathways. These technologies are designed to increase safety and reduce surgical manipulation. A growing trend in the field of glaucoma is the development of procedures that can be performed in conjunction with cataract surgery with little additional anesthesia and minimal effects on refractive error.

Innovation in glaucoma surgery has lagged when compared with the fields of cataract and refractive surgery. Trabeculectomy remains the gold standard procedure, despite the unpredictability and risk associated with intraoperative variation and patients’ healing. Glaucoma drainage devices are still the most commonly used second-line surgical interventions for glaucoma. These implants have changed little during the past 30 years.

The trend toward minimally invasive glaucoma surgery (MIGS) began with the introduction of endocyclophotocoagulation (ECP), canaloplasty, ab interno trabeculotomy, and the Ex-Press Glaucoma Filtration Device (Alcon Laboratories, Inc., Fort Worth, TX). All are currently available in the United States and have been in use for a number of years. Canaloplasty has emerged as an effective procedure that lowers IOP over an extended period of time by augmenting the eye’s natural outflow apparatus. Canaloplasty appears to decrease the IOP through the creation of a Descemet window and the dilation and tensioning of the trabecular meshwork.

Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=40916

Glaucoma is an ocular disease which affects the optic nerve of the iris and progression of the same results in vision loss and blindness. According to the World Health Organization (WHO), glaucoma is the most cause of blindness across the world. Currently, there are no existing treatments for glaucoma; however, some commercially available therapies focus on reducing the intraocular pressure, which is responsible for the development and progression of the disease. The treatment for glaucoma starts with topical eye drops, which is an alternative used to delay surgery.

Photodynamic therapy and laser therapy are effective solutions that perform well with surgery options. Rise in the number of glaucoma cases, easy availability of medical insurance coverage for diagnosis and treatment, and growth in demand for minimally invasive glaucoma surgeries are expected to drive the global glaucoma surgery devices market during the forecast period. Furthermore, increase in health care expenditure and rise in geriatric population are expected to fuel the glaucoma surgery devices market during the forecasted period.

The global glaucoma surgery devices market can be segmented into types of product, types of surgery, end-user, and region. Based on product type, the market is segregated into punches, USC planer, USC marker, USC shaver, Alger brushes and probes, forceps, glaucoma drainage devices, knives, and others. In terms of types of surgery, the glaucoma surgery devices market can be divided into minimally invasive glaucoma surgeries (MIGS), tube shunt implantation, trabeculectomy, cyclophotocoagulation, and others.

Pre Book Glaucoma Surgery Devices Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=40916<ype=S

Among these segments, the MIGS segment is anticipated to dominate the market during the forecasted period owing to rising demand for minimally invasive and patient-friendly procedures. Based on end-user, the glaucoma surgery devices market can be categorized into diagnostic centers, eye-hospitals, and others.

The global glaucoma surgery devices market has a presence of several regional players which have a huge market share in emerging countries operating at regional or country level. In terms of geography, the global glaucoma surgery devices market can be divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The U.S. dominates the market due to the increase in acceptance of treatment options. Additionally, rising awareness among patients regarding glaucoma and the introduction of favorable reimbursement policies are anticipated to fuel the glaucoma surgery devices market in North America during the forecast period.

Europe is the second largest market for the glaucoma surgery devices market. The market in Asia Pacific, especially in countries such as India, China, and Japan, is anticipated to expand at a rapid pace in the next few years due to rising awareness regarding glaucoma surgeries and booming medical tourism in this region. The market in Middle East and Africa and Latin America is projected to expand at a sluggish pace in the near future.

Major players operating in the global glaucoma surgery devices market are Abbott Laboratories, Glaukos Corporation, Alcon, Inc., ASICO, Carl Zeiss Meditec AG, Katalyst Surgical, Nidek Co., Ltd., Lumenis Ltd., Ziemer Ophthalmic Systems AG, and Iridex Corporation.

Contact

Transparency Market Research,

90 Sate Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com/

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

This release was published on openPR.